Company Filing History:
Years Active: 2011
Title: Michael B Becknell: Innovator in Hematopoietic Progenitor Cell Research
Introduction
Michael B Becknell is a notable inventor based in Westerville, OH (US). He has made significant contributions to the field of immunology, particularly in the area of hematopoietic progenitor cells. His work focuses on the isolation and application of specific cell types that play a crucial role in immune response.
Latest Patents
Becknell holds a patent for "CD34(+) cells and their methods of use." This invention provides isolated cells that are selectively enriched for hematopoietic progenitor cells, which are precursors for natural killer (NK) cells. The cells are characterized as both CD34 and CD45RA positive and express C-integrin β. The patent outlines methods for isolating these cells, inducing the formation of CD56 NK cells, and treating diseases associated with immunodeficiency and cancer.
Career Highlights
Michael B Becknell is affiliated with The Ohio State University, where he continues to advance research in his field. His innovative work has garnered attention and recognition within the scientific community.
Collaborations
Becknell has collaborated with esteemed colleagues, including Michael A Caligiuri and Aharon G Freud. These partnerships have further enriched his research and contributed to advancements in immunology.
Conclusion
Michael B Becknell's contributions to the field of hematopoietic progenitor cells and immunology are noteworthy. His patent and ongoing research at The Ohio State University highlight his commitment to advancing medical science and improving treatment options for diseases related to immunodeficiency and cancer.